Recursion Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India. This move aligns with Mubadala's strategy to generate sustainable financial returns. They have made significant investments globally and are now looking to expand their presence in India's healthcare landscape.

The AI chip giant, in its first-ever 13F filing with the SEC, also announced small stakes in Recursion Pharmaceuticals (RXRX) and self-driving company…

The closing finished well above its original target and represents one of the largest first-time private life sciences growth funds.

Artificial intelligence is changing life as we know it. These companies are some of the biggest movers and shakers in this brave new world.

Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers at The University of Texas MD Anderson Cancer Center.